H.R. 2343John W. Walsh Alpha-1 Home Infusion Act of 2025
Progress: Introduction / referral onlyLatest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
119th CongressPolicy area: Health
- Troy A. CarterCosponsorJun 30, 2025
Official CRS summary
Official CRS summary (Introduced in House version) · Congress.gov(opens in a new tab)
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.